Xingantie

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameXingantie
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeking University
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A